This platform was created as a comprehensive resource for clinicians managing urothelial and prostate cancers, offering access to clinical protocols, molecular updates, treatment algorithms, and educational content curated by experts from across the Kingdom.
Through collaboration, knowledge-sharing, and innovation, the Saudi GU Working Group is committed to transforming the landscape of urothelial and prostate cancer care, driving better outcomes for patients, and supporting healthcare providers every step of the way.